Linda S. Palczuk
Ms. Linda S. Palczuk was elected to the board of directors in July of 2018. She serves as the Chief Operating Officer of Verrica Pharmaceuticals, Inc., a late-stage biopharmaceutical company focused on medical dermatology products, a position she has held since February 2018. Prior to joining Verrica Pharmaceuticals, from July 2017 to February 2018, Ms. Palczuk was President and Chief Executive Officer at Osiris Therapeutics, Inc., a regenerative medicines biotechnology company. Prior to her position at Osiris Therapeutics, Ms. Palczuk had an extensive and successful 30-year career with AstraZeneca Pharmaceuticals and its legacy companies, serving in senior-level commercial and general management roles, including Vice President, Established Brands; Vice President, Global Commercial Excellence; Vice President, Sales & Marketing and Vice President, Sales. Ms. Palczuk received her undergraduate degree in Biology from Franklin and Marshall College and an MBA from the Alfred Lerner College of Business and Economics at the University of Delaware.